Page 776«..1020..775776777778..790800..»

Chronic PDE5i Treatment Found to Improve Cardiac Remodeling in Men, but Not Women, With Diabetic Cardiomyopathy – Endocrinology Advisor

Posted: Published on June 12th, 2020

After careful consideration, the Endocrine Society canceled its annual meeting (ENDO 2020), which was set to take place in San Francisco, California, from March 28 to 31, 2020, because of concerns regarding coronavirus disease 2019 (COVID-19). Research findings that were scheduled to be presented at the meeting have been published in a supplemental issue of the Journal of the Endocrine Society. The society is hosting ENDO Online, a complimentary virtual event featuring on-demand and live programming, from June 8 to 22, 2020, to provide a platform for continued learning and research exhibition. Continue reading →

Posted in Ventricular Remodeling | Comments Off on Chronic PDE5i Treatment Found to Improve Cardiac Remodeling in Men, but Not Women, With Diabetic Cardiomyopathy – Endocrinology Advisor

Multi-Society Guidelines on the Use of Multimodality CV Imaging in Competitive Athletes – The Cardiology Advisor

Posted: Published on June 12th, 2020

A set of guidelines regarding the use of multimodality cardiovascular (CV) imaging in young adult competitive athletes, focusing on the distinction between exercise-induced cardiac remodeling (EICR) and cardiac pathology, was formulated by an expert writing group and published in the Journal of the American Society of Echocardiography. This report was endorsed by the American Society of Echocardiography, in conjunction with the Society of CV Computed Tomography (CT) and the Society for CV Magnetic Resonance (CMR). Young competitive athletes with unrecognized CV disease (CVD) who undergo strenuous exercise may be at increased risk for serious adverse events, including sudden cardiac death. Continue reading →

Posted in Ventricular Remodeling | Comments Off on Multi-Society Guidelines on the Use of Multimodality CV Imaging in Competitive Athletes – The Cardiology Advisor

Cardiac Restoration Systems Market to Make Great Impact in Near Future by 2026 – The Canton Independent Sentinel

Posted: Published on June 12th, 2020

As per a report published by National Heart, Lung, and Blood Institute (NHLBI), heart failure incidences continue to rise in the United States with approximately 825,000 new cases diagnosed in 2013. As per NHLBI, 5.1 million Americans over the age of 20 have heart failures and this number is projected to increase by 46% to reach 8 million by 2030. Cardiac restoration systems are usually used after a coronary artery bypass grafting and may precede or be followed by mitral valve repair or other procedures such as endocardectomy and cryoablation Continue reading →

Posted in Ventricular Remodeling | Comments Off on Cardiac Restoration Systems Market to Make Great Impact in Near Future by 2026 – The Canton Independent Sentinel

Bringing More Than Heat: Gibson’s career is baseball, but his passion stems from charity and plenty of personality – Greenfield Daily Reporter

Posted: Published on June 12th, 2020

ST. LOUIS Zipping around the Texas Rangers spring training complex at Surprise Stadium just northwest of Phoenix, Kyle Gibson is miced up and heading to the players parking lot Continue reading →

Posted in Ulcerative Colitis | Comments Off on Bringing More Than Heat: Gibson’s career is baseball, but his passion stems from charity and plenty of personality – Greenfield Daily Reporter

Graduate aims to make a difference amid challenges of lab work on COVID-19 project – SFU News – Simon Fraser University News

Posted: Published on June 11th, 2020

Abeline Watkins hopes the data she is discovering as part of SFU professor Peter Rubens Molecular Cardiac Physiology Group may one day make a difference in addressing the ongoing COVID-19 pandemic. Watkins is investigating whether Cannabidiol (CBD), a non-psychoactive component of cannabis sativa, can help to mitigate the negative side effects of taking Azithromycin, a drug that has been proposed to treat symptoms of COVID-19, particularly lung problems. The research is being funded by her second Undergraduate Student Research Award (USRA) for sciences, awarded by the Natural Sciences and Engineering Research Council (NSERC). Continue reading →

Posted in Molecular Cardiology | Comments Off on Graduate aims to make a difference amid challenges of lab work on COVID-19 project – SFU News – Simon Fraser University News

Dapagliflozin Benefits in HF Regardless of Diuretics: DAPA-HF – Medscape

Posted: Published on June 11th, 2020

The DAPA-HF trial has already changed cardiology in opening up a new class of drugs to patients with heart failure (HF), whether or not they have diabetes. Now the trial is yielding clues as to how it benefits them Continue reading →

Posted in Clinical Cardiology | Comments Off on Dapagliflozin Benefits in HF Regardless of Diuretics: DAPA-HF – Medscape

Optical mapping used to assess effect of hydroxychloroquine on heart rhythm – Cardiac Rhythm News

Posted: Published on June 11th, 2020

Researchers have used an optical mapping system to observe how the malaria drug hydroxychloroquine, which has been touted as a possible treatment for COVID-19, creates disturbances in heart rhythm in an animal model. The research, published in the journal Heart Rhythm, found that the drug made it surprisingly easy to trigger arrhythmias in two types of animal hearts by altering the timing of electrical waves that control heartbeat. We have illustrated experimentally how the drug actually changes the waves in the heart, and how that can initiate an arrhythmia, said Flavio Fenton, a professor in the School of Physics at the Georgia Institute of Technology (Atlanta, USA) and the papers corresponding author Continue reading →

Posted in Clinical Cardiology | Comments Off on Optical mapping used to assess effect of hydroxychloroquine on heart rhythm – Cardiac Rhythm News

Philips Lumify handheld ultrasound solution launched in Japan to enable powerful diagnostics at the bedside – GlobeNewswire

Posted: Published on June 11th, 2020

June 11, 2020 04:00 ET | Source: Royal Philips photo-release June 11, 2020 Amsterdam, the Netherlands Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced thatits Lumify with Reacts handheld tele-ultrasound solution is now commercially available in Japan. Continue reading →

Posted in Clinical Cardiology | Comments Off on Philips Lumify handheld ultrasound solution launched in Japan to enable powerful diagnostics at the bedside – GlobeNewswire

Cardiology Information System Market (Impact Of Covid-19) To See Massive Growth By 2027 | Change Healthcare, Esaote Spa, Fujifilm – Medic Insider

Posted: Published on June 11th, 2020

Cardiology information system (CIS) works mainly on the similar lines of radiology PACS; however, it primarily focuses on the retrieval of cardiology-centric images. The most common clinical benefit that cardiology information system provides is the ability for cardiologists and the staff to carry out their daily duties from one system. A successfully implemented CIS solution enables organizations to update and enhance the cardiovascular service line in a healthcare set up. Continue reading →

Posted in Clinical Cardiology | Comments Off on Cardiology Information System Market (Impact Of Covid-19) To See Massive Growth By 2027 | Change Healthcare, Esaote Spa, Fujifilm – Medic Insider

Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension – TCTMD

Posted: Published on June 11th, 2020

New observational data from Wuhan, China, suggest that hypertensive patients hospitalized with COVID-19 had a twofold increased risk of dying compared to those without hypertension, and that not being on medication for hypertension at the time of hospitalization worsens outcomes. The study also provides additional reassurance about the use of antihypertensives that target the renin-angiotensin-aldosterone system (RAAS). Patients with RAAS inhibitors were not exposed to a higher risk of mortality in our study and, after pooling previously published data in a study-level meta-analysis, the use of RAAS inhibitors was shown to be possibly associated with lower risk of mortality, write Chao Gao, MD (Xijing Hospital, Xian, China), and colleagues. Continue reading →

Posted in Clinical Cardiology | Comments Off on Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension – TCTMD

Page 776«..1020..775776777778..790800..»